Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2728 results

Sort By:

The TAIL-PrEP Study

Study ID: NCT06868641
Start Date: 2026-01
End Date: 2027-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

TAIL-PrEP

Sponsor

Columbia University

Source: clinicaltrials.gov

Share:
Add to list

Intravascular Neuro OCT Imaging System for Aneurysm Treatment Evaluation

Study ID: NCT07214220
Start Date: 2026-02-01
End Date: 2029-02-28
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

67

Intervention / Treatment

Endovascular Intracranial aneurysm treatment

nOCT imaging

Sponsor

Spryte Medical

Source: clinicaltrials.gov

Share:
Add to list

A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia

Study ID: NCT07134088
Start Date: 2025-11-21
End Date: 2030-06-18
Study Type

Interventional

Study Phase

Phase2

No. of Participants

104

Intervention / Treatment

Blinatumomab

Sponsor

Amgen

Source: clinicaltrials.gov

Share:
Add to list

Acarbose in Combination with Standard Therapy in Metastatic Renal Cell Carcinoma (RCC)

Study ID: NCT05487859
Start Date: 2025-12-31
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

24

Intervention / Treatment

Acarbose Tablets

Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list

Upper Body Subcutaneous Exosome Release in Response to a Meal in Obesity

Study ID: NCT07031297
Start Date: 2025-12
End Date: 2027-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Meal Study

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

Study ID: NCT07202546
Start Date: 2025-11-28
End Date: 2029-03-19
Study Type

Interventional

Study Phase

Phase2

No. of Participants

550

Intervention / Treatment

VH4524184

Emtricitabine (FTC) and tenofovir alafenamide (TAF) Fixed Dose Combination (FDC) tablets

Dolutegravir / Lamivudine (DTG/3TC)

Sponsor

ViiV Healthcare

Source: clinicaltrials.gov

Share:
Add to list

Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest

Study ID: NCT03176186
Start Date: 2026-03
End Date: 2030-05
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1436

Intervention / Treatment

Xenon

Sponsor

Invero Pharma, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Therapeutic Strategies to Reduce Endothelial Ischemia-reperfusion Injury

Study ID: NCT06825143
Start Date: 2026-10-01
End Date: 2030-06-30
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

68

Intervention / Treatment

Ischemic preconditioning

Intravenous lactate infusion

No ischemic preconditioning (control)

Normal Saline Infusion (Placebo)

Ischemic preconditioning and intravenous lactate

Sponsor

Gary Van Guilder

Source: clinicaltrials.gov

Share:
Add to list

Precision-Medicine Diagnostic Support in Hospitalized Veterans With Acute Kidney Injury

Study ID: NCT07217808
Start Date: 2028-01-01
End Date: 2029-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

PRECISE-AKI Clinical Decision Support Tool

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Study ID: NCT07022678
Start Date: 2026-01-20
End Date: 2032-06-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

556

Intervention / Treatment

Best Practice

Biospecimen Collection

Cytarabine

Electronic Health Record Review

Placebo Administration

Xylitol-containing Oral Wipe

Sponsor

Children's Oncology Group

Source: clinicaltrials.gov

Share:
Add to list